Panagiota Manolopoulos

Greek-American Clinical Pharmacist passionate about immunology, rare disease, neurology, cardiology and research 🫀🥼 #WomeninSTEM 👩🏻‍🔬Amgen US

[Panagiota Manolopoulos @PanagiotaManolo]

@pnatarajanmd @Amgen Welcome to Amgen!

[Amgen 🧪🔬🧬 @Amgen]

NEWS: A new treatment option for adults with AChR+ or MuSK+ generalized myasthenia gravis (#gMG) has been approved in the U.S. 🔗 https://t.co/uqNLvrNIgr

#RareDisease $AMGN

[California Thoracic Society @CalThoracic]

Register for our webinar on October 25th at 5pm PT
🔗 https://t.co/PyI5PtkFo8

COPD with Type 2 Inflammation: A Spark For Deeper COPD Understanding w/ Joseph E. Khabbaza, MD

Developed by the California Thoracic Society in collaboration with Regeneron Pharmaceuticals Inc.

[Marcos Nascimento, MD Pulmão: S.A. @PulmaoSA]

Why we MUST prevent #exacerbation in #COPD in general & mainly in COPD patients with type 2 inflammation?
1️⃣ Single moderate exacerbation/ year prior 2 diagnosis ⬆️ subsequent COPDAE risk
2️⃣ & Frequent or severe COPDAE prior 2 diagnosis associated with a higher risk!
🎯 BloodEOS

[Alfredo Pachas @AlfredoPachasMD]

🔥🔥"Identifying #Super-#Responders: a Review of the Road to #Asthma #Remission"

🌬️ Asthma Remission: Thanks to advanced treatments, asthma remission is now possible. Patients with profound responses are called "super-responders."

🧬 Type 2 Inflammation: Identifying Type 2 inflammation (#T2) is the key to a super-response. 🔍 Biomarkers like #eosinophils and #FeNO predict the success of biological therapies.

⚖️ Comorbidities and Limitations: #Obesity, #mooddisorders, and #smoking reduce the likelihood of success. A multidisciplinary approach is essential. 🚶‍♂️🍎🧠

⏳ Asthma #Duration:📉 Long-standing, uncontrolled asthma worsens lung function and limits remission potential. The longer it persists, the harder it is to reverse the damage.

💉 #Biologic Treatments: Therapies like anti-IL-5 and anti-TSLP are transforming severe asthma management. 💪 They reduce mucus plugs and improve lung function.

🛑 Remission and Super-Response Criteria: There's no consensus on remission. 🚑 Key factors include no exacerbations and significant improvement in lung function.

🚀 #Predict and #Prevent #Approach: The future of asthma treatment is proactive, using biomarkers for early intervention. 🔍 This approach prevents lung damage before severe symptoms develop.

📊 Need for New Clinical Trials: Future trials should focus on patients with moderate asthma, preventing irreversible damage. Early biological treatment can change the disease course! 🧑‍⚕️💡

▶️https://t.co/ObCxi5rcsT

@simcouillard @pulmonology101

[California Thoracic Society @CalThoracic]

Register for our webinar on October 25th at 5pm PT
🔗 https://t.co/PyI5PtkFo8

COPD with Type 2 Inflammation: A Spark For Deeper COPD Understanding w/ Joseph E. Khabbaza, MD

Developed by the California Thoracic Society in collaboration with Regeneron Pharmaceuticals Inc.

[Advances in Therapy @AdvancesTherapy]

Reduced Sense of Smell in Patients with Severe Chronic #Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative #Review

Read the full open-access review here: https://t.co/7x8kOXTsqH

#anosmia #benralizumab #dupilumab #mepolizumab #omalizumab

[Sanofi @sanofi]

The @US_FDA has approved our medicine as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. This marks the first-ever biologic approved for COPD.

CC: @Regeneron

[Heart Rhythm TV @HeartRhythmTV]

BREAKING: #HRS2024 Day 1 is in the books! From the PFA Live Case Summit, Africa Summit, Business of EP Sessions, and more, it was the beginning of an electrifying meeting. Stay tuned to #HRStv for all of your Boston coverage #EPeeps. See the full interview here ➡️ https://t.co/b54NPCeqK3

[Nikhil Shah, MD @NikhilShahMD]

Starting off #HRS2024 the right way! #Boston #EPeeps

[Heart Rhythm Society @HRSonline]

Curious about what sessions your peers are going to attend at #HRS2024? Check out these top session picks from your #2024PaceSetters ➡️ https://t.co/44NbuMM4vB

Not registered? ➡️ https://t.co/VrcHIf9NJq

#EPeeps #MedEd #socialambassador @AhmedNagyMD @BrototoD @dredcronin @Ariat104 @kcole_12 @omarjavedbaqal @DrRachitaEP @SchakrabartiEP @srissundaram @simovicst

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

@netta_doc @DBelardoMD @JGrapsa Trainees in cardiology in Greece 🇬🇷 are almost 40% women! 👏🏽👏🏽 that is quite impressive! @WomenAs1

[EHJ Editor-in-Chief @ehj_ed]

Earlier diagnosis of AF is associated with a higher hazard ratio of subsequent myocardial disease and shorter life expectancy. Read more in #EHJ
#atrialfibrillation #CardioTwitter @escardio @ESC_Journals

https://t.co/zs1qpjbiz0

[Panagiota Manolopoulos @PanagiotaManolo]

@SteliosTzeis Congratulations Dr. Tzeis! Excellent consensus statement. PS. My husband is from Filothei. I am from Kyparissia 🇬🇷grew up as Greek Americans in Chicago and Arizona.

[Stelios Tzeis @SteliosTzeis]

The 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus on Catheter and Surgical AF Ablation has just been presented and released!
https://t.co/aXM4G1VGid…
Kudos to all 44 members that made it happen @Ed_Gerst @JonKalmanEP @EduardoSaad3

[Stefan Simović @simovicst]

@atulverma_md @atulverma_md also on AADs, post-ablation monitoring, early recurrence and trial endpoints
#EHRA2024

[Stefan Simović @simovicst]

@atulverma_md on optimal patient management:
-Same-day discharge for uncomplicated ablations
-Anticoagulation after AF ablation should depend on CHA2DS2-VASC score
#EHRA2024

[JK Han MD @netta_doc]

Post #AFib #ablation blanking period has been reduced from 12 weeks down to *8 weeks* due to high prediction of late recurrence - 60X!

From the new #EHRA2024 Guidelines on Catheter ablation:

🔗https://t.co/V5hz3YOKax

[JK Han MD @netta_doc]

Caution from @DrJasonAndrade:

Are your #AFib patients truly “asymptomatic”? Many are *symptomatic* when assessed appropriately (ie after DCCV)

Importantly, sympt presence/absence *do not* modulate #stroke, #HF or CV outcomes- everyone deserves #OAC & ABC Rx

#EHRA2024

[Justin Z Lee @DrJustinZLee]

Total solar eclipse in Cleveland. Happy to have a short down time in between cases to capture this! @ClevelandClinic